# Allogeneic Transplantation From Related Haploidentical Donors

> **NCT00185692** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 16 (actual)

## Conditions studied

- Blood Cancer
- Leukemia
- Graft Versus Host Disease
- Malignancy
- CLL
- NHL
- Hodgkin's Disease
- MDS

## Interventions

- **PROCEDURE:** non-myeloablative hematopoietic cell transplantation
- **DRUG:** Anti-Thymocyte Globulin
- **DRUG:** Cyclosporine
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** G-CSF
- **DRUG:** Solumedrol
- **DRUG:** Acetaminophen
- **DRUG:** Diphenydramine
- **DRUG:** Hydrocortisone

## Key facts

- **NCT ID:** NCT00185692
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185692, "Allogeneic Transplantation From Related Haploidentical Donors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00185692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*